CP-122721

CP-122721 Uses, Dosage, Side Effects, Food Interaction and all others data.

CP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome.

Table Of contents

• CP-122721
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	CP-122721
Generic	CP-122721
Type
Formula	C20H23F3N2O2
Weight	Average: 380.404 Monoisotopic: 380.171162605
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in asthma, depression, and irritable bowel syndrome (IBS).

How CP-122721 works

CP-122721 interacts with high affinity at the human NK1 receptor expressed in IM-9 cells.

Innovators Monograph

You find simplified version here CP-122721